SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,007,142 | -18.1% | 580,600 | -10.7% | 0.26% | -7.5% |
| Q2 2023 | $19,546,695 | +339.1% | 650,256 | +429.2% | 0.28% | +329.2% |
| Q1 2023 | $4,451,979 | +12.4% | 122,881 | +10.7% | 0.06% | +22.6% |
| Q4 2022 | $3,961,011 | -1.9% | 111,046 | -6.9% | 0.05% | -8.6% |
| Q3 2022 | $4,038,000 | +69.5% | 119,278 | +44.8% | 0.06% | +70.6% |
| Q2 2022 | $2,383,000 | +25.0% | 82,400 | +39.7% | 0.03% | +54.5% |
| Q1 2022 | $1,907,000 | -80.8% | 59,000 | -89.3% | 0.02% | -88.6% |
| Q1 2020 | $9,945,000 | -27.2% | 552,800 | -4.0% | 0.19% | -10.6% |
| Q4 2019 | $13,653,000 | +19.3% | 575,600 | +38.2% | 0.22% | +1.4% |
| Q3 2019 | $11,448,000 | -25.9% | 416,600 | -10.8% | 0.21% | -19.3% |
| Q2 2019 | $15,453,000 | +51.5% | 467,000 | +60.5% | 0.26% | -52.9% |
| Q1 2019 | $10,197,000 | -11.1% | 291,000 | -15.7% | 0.56% | -25.6% |
| Q4 2018 | $11,464,000 | -41.1% | 345,100 | -10.7% | 0.75% | -38.9% |
| Q3 2018 | $19,460,000 | -0.4% | 386,500 | +18.3% | 1.23% | -25.9% |
| Q2 2018 | $19,547,000 | +47.8% | 326,600 | +13.1% | 1.67% | +27.2% |
| Q1 2018 | $13,227,000 | +38.1% | 288,800 | +20.1% | 1.31% | +30.9% |
| Q4 2017 | $9,580,000 | +186.7% | 240,400 | +46.6% | 1.00% | +59.1% |
| Q2 2016 | $3,341,000 | -50.3% | 164,000 | -62.8% | 0.63% | -48.4% |
| Q1 2016 | $6,725,000 | – | 441,000 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |